BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3180099)

  • 1. A Mr 58,000 glycoprotein specifically expressed in developing hamster pancreas and reexpressed in hamster and human pancreatic carcinomas.
    Heredia A; Escribano MJ
    Cancer Res; 1988 Dec; 48(23):6906-11. PubMed ID: 3180099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal pancreatic antigens in the Syrian golden hamster and their relationship to development and carcinogenesis.
    Benedi VJ; Escribano MJ; Zuinghedau J; Burtin P
    Cancer Res; 1984 Mar; 44(3):1135-41. PubMed ID: 6362857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncofetal proteins of the exocrine pancreas].
    Escribano M; Heredia A; Carré-Llopis A
    Bull Cancer; 1990; 77(1):75-81. PubMed ID: 2317578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid binding protein in human and experimental pancreatic carcinomas in hamsters.
    Brandes M; Gesell MS; Ueda H; Millan JC; Quinlan RM; Ernst C; Sindelar WF; Kurman CC; Harris S; Brandes D
    Ann Clin Lab Sci; 1983; 13(5):400-6. PubMed ID: 6314868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of a Mr 78,000 marker in chemically induced transplantable carcinomas and primary carcinoma of human pancreas.
    Parsa I
    Cancer Res; 1988 Apr; 48(8):2265-72. PubMed ID: 3349490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a rat hepatic oncofetal membrane glycoprotein.
    Faris RA; McEntire KD; Thompson NL; Hixson DC
    Cancer Res; 1990 Aug; 50(15):4755-63. PubMed ID: 1695125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of three monoclonal antibodies specifically reactive respectively with the ductal, acinar and islet cells of the human pancreas.
    Shibata K; Kobayashi T; Matsuura N; Shimano T; Mori T
    Jpn J Clin Oncol; 1991 Feb; 21(1):13-21. PubMed ID: 1648632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
    Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
    Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients.
    Wang X; Wang S; Tang X; Zhang A; Grabinski T; Guo Z; Hudson E; Berghuis B; Webb C; Zhao P; Cao B
    J Immunol Methods; 2010 Oct; 362(1-2):151-60. PubMed ID: 20869966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological detection of an oviductal glycoprotein in the rat.
    Abe H; Abe M
    J Exp Zool; 1993 Jul; 266(4):328-35. PubMed ID: 8354994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
    Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
    Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunolocalization of the monoclonal antibody J28 in early transformation stages in N-nitrosobis(2-hydroxypropyl)amine-induced pancreatic tumors in the Syrian golden hamster.
    Takeda Y; Miralles F; Daher N; Escribano MJ
    J Cancer Res Clin Oncol; 1992; 118(5):377-85. PubMed ID: 1583067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies.
    Yuan SZ; Ho JJ; Yuan M; Kim YS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6179-87. PubMed ID: 4063969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.
    Momburg F; Moldenhauer G; Hämmerling GJ; Möller P
    Cancer Res; 1987 Jun; 47(11):2883-91. PubMed ID: 3552208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane-induced rat colon tumors and human colon cancer cell lines.
    Laferté S; Prokopishyn NL; Moyana T; Bird RP
    J Cell Biochem; 1995 Jan; 57(1):101-19. PubMed ID: 7536750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of the expression of fetal acinar antigens during carcinogenesis of the pancreas in hamsters: individual follow-up by open biopsy.
    Eriguchi M; Carré-Llopis A; Orbach-Arbouys S; Escribano J
    J Natl Cancer Inst; 1987 Mar; 78(3):519-25. PubMed ID: 3469464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of intermediate filaments in normal and neoplastic exocrine pancreas.
    Santini D; Ceccarelli C; Martinelli GN; Pasquinelli G; Leone O; Marrano D; Mancini AM
    Zentralbl Pathol; 1994 Aug; 140(3):247-58. PubMed ID: 7524653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.